Pamela Thornton
Nurse Practitioner · Fort Wayne, INNPI 1609361062
Payments from drug & device makers
Across 161 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$470
- Otsuka America Pharmaceutical, Inc.$435
- Sunovion Pharmaceuticals Inc.$328
- Lundbeck LLC$230
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$211
- Alkermes, Inc.$196
- plus $613 from 11 others
What the payments were for
- Food & beverage$2,484100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $470 |
| Otsuka America Pharmaceutical, Inc. | 18 | $435 |
| Sunovion Pharmaceuticals Inc. | 19 | $328 |
| Lundbeck LLC | 28 | $230 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $211 |
| Alkermes, Inc. | 11 | $196 |
| Neurocrine Biosciences, Inc. | 9 | $164 |
| Teva Pharmaceuticals USA, Inc. | 6 | $94 |
| Corium, LLC | 4 | $82 |
| Johnson & Johnson | 5 | $73 |
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Eisai Inc. | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
How this compares
$2,484 in reported general payments places this provider in the 85th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 26 | $37,073 |
| RexultiBrexpiprazole | 16 | $26,034 |
| TrintellixVortioxetine Hydrobromide | 14 | $8,478 |
| Paliperidone ErPaliperidone | 13 | $3,850 |
| Oxcarbazepine | 27 | $1,865 |
| Trazodone Hcl | 79 | $1,565 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 29 | $1,056 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 16 | $1,012 |
| Aripiprazole | 39 | $1,011 |
| Buspirone Hcl | 67 | $830 |
| Clozapine | 11 | $766 |
| Haloperidol Decanoate | 15 | $571 |
| Olanzapine | 37 | $566 |
| Bupropion XlBupropion Hcl | 41 | $512 |
| Haloperidol | 16 | $461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $470 | $37,07326 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $435 | $26,03416 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $17 | $8,47814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Fort Wayne
- Sean GoddardFort Wayne$180K
- Kristine TaylorFort Wayne$69K
- Mary BullisFort Wayne$27K
- Nathan MinerFort Wayne$21K
- Joel NagelFort Wayne$20K
- Gabriela NorthFort Wayne$18K
- Karen LothamerFort Wayne$12K
- Pamela ShodaFort Wayne$11K
- Sara CoburnFort Wayne$9K
- Marlise FletterFort Wayne$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.